Related Experiment Video

Updated: May 12, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Hypertension and chronic kidney disease: controversies in pathogenesis and treatment

J L Pirkle1, B I Freedman

  • 1SectioDepartment of Internal Medicine, Wake Forest School of Medicine,Winston-Salem, NC 27157-1053, USA.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|March 30, 2013
PubMed

Insights

Hypertension and chronic kidney disease (CKD) link is clarified by genetic research. The Systolic Blood Pressure Intervention Trial (SPRINT) will provide insights into optimal blood pressure control for kidney and heart health.

Area of Science:

  • Nephrology
  • Cardiology
  • Genetics

Background:

  • The interplay between hypertension and chronic kidney disease (CKD) remains controversial.
  • Understanding the causal relationship and optimal treatment targets is crucial for patient outcomes.

Purpose of the Study:

  • To review molecular genetics breakthroughs clarifying the hypertension-kidney disease relationship.
  • To discuss the role of hyperuricemia in hypertension and CKD pathogenesis.
  • To examine current blood pressure treatment guidelines for CKD populations.

Main Methods:

  • Review of molecular genetics research.
  • Analysis of hyperuricemia's role in disease pathogenesis.
  • Discussion of existing hypertension treatment guidelines.
  • Anticipation of results from the Systolic Blood Pressure Intervention Trial (SPRINT).

Main Results:

  • Molecular genetics advances are clarifying the sequence of hypertension and kidney disease.
  • Hyperuricemia is implicated in the pathogenesis of both conditions.
  • The SPRINT trial is expected to yield significant data on optimal blood pressure targets.

Conclusions:

  • Recent genetic discoveries are resolving long-standing controversies in hypertension and CKD.
  • The SPRINT trial promises to offer critical evidence for managing hypertension in CKD patients.
  • Future findings will likely refine hypertension management strategies, impacting cardiovascular and cognitive health.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...